Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 70 for “"Fenofibrate"”.
-
Fenofibrate and Insulin Resistance
Both animal and human models suggest that fenofibrate, a medication widely prescribed to decrease triglycerides, also decreases insulin resistance. In the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) cohort, which included 780 individual who took 160 mg of micronized fenofibrate daily …
-
Molecular mechanism of the anti-inflammatory effect of fenofibrate.
Summary abstract not available.
-
Formulation and Evaluation of Fenofibrate-HPꞵCD Tablets Using the Freeze-Drying Method
Fenofibrate (FNB) is a lipid-lowering medication used to treat hyperlipidemia that is practically insoluble in Water, leading to reduced absorption gastrointestinal tract. Complexation and lyophilization are performed and studied to enhance the solubility of the FNB in gastric fluid and increase …
-
Studies investigating the impact of select genotypes on the pharmacological effect of fenofibrate
… that tested the effect of combining statins and fenofibrate, posed a challenge in using this antidyslipidemic medication. One significant challenge of using fenofibrate is the high inter-subject variability in lipid response, which can range from -82 to 132% for triglyceride change from baseline. …
-
Development of Fenofibrate Solid Dispersion Via Hot Melt Extrusion and 3D Printing Technologies
… develop an amorphous solid dispersion (ASD) of fenofibrate using Hot Melt Extrusion (HME) and 3D printing. By using HME, 3D printable filaments were prepared. Fenofibrate (10% w/w), Soluplus®, and Polyethylene oxide-N80 were used to prepare the HME filaments. The filaments were divided into two …
-
Formulation and In-Vitro Evaluation of Fenofibrate Capsules Using Hot Melt Extrusion Technology
… to prepare the filaments of insoluble model drug Fenofibrate (FBR). Eudragit® E PO® was used as a immediate release, moisture content control polymer for the formulation. Soluplus was used as a solubility enhancement polymer. Differential scanning calorimetry (DSC) and Fourier-Transform Infrared …
-
Crystallisation of amorphous fenofibrate and potential of the polymer blend electrospun matrices to stabilise in its amorphous form
Fenofibrate was chosen as the drug of interest in this study because of its poor water-solubility, highly unstable amorphous state and unpredictable crystallisation behaviour. The crystallisation behaviour of amorphous fenofibrate is essential information that primarily corresponds to the physical …
-
The interaction between glucose and fat metabolism and insulin resistance in severely burned children and the metabolic effects of fenofibrate
… proliferator activating receptor alpha agonist fenofibrate. \r\nThe final two studies focused on burn trauma in children. Children who experience severe flame burn rapidly develop insulin resistance and hyper-metabolic fat, protein and glucose regulation. This insulin resistance has been linked …
-
Developing modulators of tumour hypoxia through inhibition of cellular oxygen consumption
… work by the Higgins group has identified fenofibrate, a hyperlipidemia prodrug, to strongly reduce OCR in vitro.5 Fenofibrate is an inhibitor of Complex I in the electron transport chain. However, in vivo fenofibrate is rapidly and completely metabolised to fenofibric acid, a compound …
-
Σύγκριση συνδυασμών υπολιπιδαιμικών φαρμάκων σε ασθενείς με μικτή δυσλιπιδαιμία
… dose of rosuvastatin (40 mg) or addition of fenofibrate or extended release nicotinic acid (ER-NA)/laropiprant (LRPT) comprises 3 possible options. Aim of the study: Aim of the study was the comparison of switch to the highest approved dose of rosuvastatin (40 mg) or the addition of …
-
Επίδραση της κολχικίνης σε συνδυασμό με φιβράτη ή Ν-ακετυλοκυστεΐνη στα επίπεδα τριγλυκεριδίων και στην αθηρωματική πλάκα σε πειραματικό πρότυπο κονίκλων
… levels, and foam cell count and volume. Fenofibrate also has antioxidant, anti-inflammatory, and anticoagulant properties while also having a beneficial effect on the vasomotor function of the endothelium. The purpose of this study is to investigate the effect of per os colchicine …
-
Mechanistic understanding of bioenabling formulation approaches to improve oral bioavailability using porcine in vivo and in silico models
… preventing drug precipitation. This study uses fenofibrate as a model drug to investigate the performance of an SLC-based formulation, delivered with hydroxypropyl methylcellulose acetate succinate (HPMCAS) as a precipitation inhibitor, in pigs. The ability of biorelevant dissolution testing to …
-
The effect of digestion and drug load on absorption of poorly water soluble drugs from self-nanoemulsifying drug delivery systems (SNEDDS)
… (tetrahydrolipstatin) was used. Halofantrine and fenofibrate were chosen as model drugs and for neither halofantrine nor fenofibrate digestion appeared to have an effect on the oral bioavailability in rats. The administration of halofantrine and fenofibrate in super-SNEDDS led to …
-
Evaluation of oral bioavailability enhancement of a BCS class II compound formulated with a supercritical CO2 process
… the solubility of BCS class II compounds. Fenofibrate was selected as the BCS class II model drug and Gelucire® 50/13 was chosen as carrier because of its self-emulsifying properties. The first step of this work was to develop an in vitro response able to evaluate the improvement of the …
-
The impact of anti-inflammatory treatment on the biochemistry and stem cell genetics of atheromatosis
… diet and were treated with colchicine plus fenofibrate or N-acetylcysteine (NAC), respectively. Results: Group A developed significantly greater thoracic and abdominal aortic atherosclerosis compared to groups B (p<0.001) and C (p<0.001). Combining colchicine with NAC resulted in stronger …
-
Application of mesoporous silica for the oral delivery of poorly water-soluble drugs
… rate of the poorly waters-soluble drug, fenofibrate by processing it with a high surface area carrier, mesoporous silica. The subsequent properties of the drug – silica composite were studied in terms of drug distribution within the silica matrix, solid state and release properties. Prior …
-
Ο ρόλος της retinol binding protein 4 (RBP4) σε άτομα με αυξημένο σωματικό βάρος και υπερτριγλυκεριδαιμία
… diet (n= 20), 2) Low-calorie low-fat diet plus fenofibrate (n= 18), 3) Low-calorie low-fat diet plus rimonabant (n= 8). At baseline, at one month and at 3 months of treatment the following measurements were performed: anthropometric measurements, serum glucose, serum insulin, lipidemic profile, …
-
Regulation and enzymatic properties of renal cytochrome P450 isoforms
… (i) to test the effect of the PPARα activator fenofibrate on the recovery of renal CYP-dependent EET and HEET production in a rat model of ANG II-induced hypertension and end-organ damage (ii) to analyze the CYP-dependent metabolism of fish oil ω-3 polyunsaturated fatty acids (ω-3 PUFAs), such …
-
Επίδραση του συνδυασμού ορλιστάτης-φαινοφιμπράτης στις λιπιδαιμικές και μεταβολικές παραμέτρους σε υπέρβαρους και παχύσαρκους ασθενείς με μεταβολικό σύνδρομο
… evaluated the long-term effects of orlistat, fenofibrate and orlistat plus fenofibrate treatment on anthropometric variables, lipid profile, and carbohydrate metabolism, as well as on LDL and HDL phenotype and activities of atherosclerosis related enzymes, in overweight and obese patients …
Page 1 of 4